PL3 - Contemporary Clinical Issues Plenary Session
| Event Time: | Monday April 23, 2018 9:15 am to 11:30 am |
| Topic(s): | Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Headache, Infectious Disease, MS and CNS Inflammatory Disease, Neuro-ophthalmology/Neuro-otology, Pain and Palliative Care, Sleep |
| Director(s): | |
| Description: | This session highlights issues most critical to practicing neurologists, including abstracts related to new therapeutic developments, clinical applications of basic and translational research, and innovative technical developments. Commentary and discussion follow each presentation. |
| Completion Message: | |
| CME Credits: | 2.25 |
| Core Competencies: |
| Start/End Time | Title | Faculty |
|---|---|---|
| 9:15 AM - 9:30 AM | Presenter: Retinal Microvasculature in Predicting Risk of Stroke Subtypes | Michelle P. Lin MD |
| 9:30 AM - 9:40 AM | Discussant: Retinal Microvasculature in Predicting Risk of Stroke Subtypes | Valerie Biousse MD |
| 9:40 AM - 9:55 AM | Presenter: Predictors of Neurodegeneration in Idiopathic REM Sleep Behavior Disorder: A Multicenter Cohort Study | Ronald Postuma MD |
| 9:55 AM - 10:05 AM | Discussant: Predictors of Neurodegeneration in Idiopathic REM Sleep Behavior Disorder: A Multicenter Cohort Study | Aleksandar Videnovic MD, MSc, FAAN |
| 10:05 AM - 10:20 AM | Presenter: Pediatric Brainstem Encephalitis Outbreak Investigation with Metagenomic Next-Generation Sequencing | Kristoffer Edgar Leon |
| 10:20 AM - 10:30 AM | Discussant: Pediatric Brainstem Encephalitis Outbreak Investigation with Metagenomic Next-Generation Sequencing | Shibani Sharon Mukerji MD |
| 10:30 AM - 10:50 AM | Neuropalliative Care | Maisha T. Robinson MD, MS |
| 10:50 AM - 11:10 AM | Biosimiliars and Non-biologic Complex Drugs | Jeffrey Alan Cohen MD |
| 11:10 AM - 11:30 AM | Neurostimulation for Headache Disorders: Current Status | Deborah I. Friedman MD, MPH, FAAN |
| Speaker | Disclosure |
|---|---|
| Valerie Biousse, MD | Dr. Biousse has received personal compensation in an editorial capacity for Up to Date Neurology. |
| Jeffrey Alan Cohen, MD | Dr. Cohen has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with consulting from Adamas, Celgene, Convelo, EMD Serono, Novartis, and PendoPharm; speaking for Mylan. Dr. Cohen has received personal compensation in an editorial capacity for Co-Editor of Multiple Sclerosis Journal – Experimental, Translational and Clinical. |
| Deborah I. Friedman, MD, MPH, FAAN | Dr. Friedman has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Alder Biopharmaceuticals, Allergan, Amgen, Biohaven, electroCore, Eli Lilly, Promius, Supernus, Teva and Zosano. Dr. Friedman has received personal compensation in an editorial capacity for Neurology Reviews. Dr. Friedman has received research support from Autonomic Technologies, Inc, Eli Lilly, Merck, Zosano. |
| Kristoffer Edgar Leon | Dr. Leon has nothing to disclose. |
| Michelle P. Lin, MD | Dr. Lin has nothing to disclose. |
| Shibani Sharon Mukerji, MD | Dr. Mukerji has nothing to disclose. |
| Ronald Postuma, MD | Dr. Postuma has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Abbvie, Biotie, Roche/Prothena, Teva Neuroscience, Jannsen, Jazz Pharmaceuticals, Novartis Canada, Theranexus, and GE HealthCare.. |
| Maisha T. Robinson, MD, MS | Dr. Robinson has nothing to disclose. |
| Aleksandar Videnovic, MD, MSc, FAAN | Dr. Videnovic has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Pfizer, Acorda, and Wilsons Therapeutics. |